<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02795390</url>
  </required_header>
  <id_info>
    <org_study_id>HKBU/KWC/PC2014</org_study_id>
    <nct_id>NCT02795390</nct_id>
  </id_info>
  <brief_title>Clinical Trial on Palliative Cancer Patients With Constipation</brief_title>
  <official_title>Chinese and Western Medicine Collaborative Studies on Palliative Cancer Patients With Constipation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hong Kong Baptist University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Caritas Medical Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yan Chai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Our Lady of Maryknoll Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hong Kong Buddhist Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Authority, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hong Kong Baptist University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is a double-blinded, randomized, placebo-controlled trial for advanced cancer patients
      with constipation. 60 patients will be randomly assigned to have individualized herbal
      intervention (treatment group) or placebo (control group) in 1:1 ratio. For the treatment
      group, MaZiRenWan 10g plus HuangQi 20g are chosen as the core prescription. Furthermore, six
      herbal granules can be added according to the syndrome differentiated for individual
      participant. Placebo is made from dextrin (76.03%), tea essence (23.61%), gardenin (0.02%),
      and caramel (0.34%) to achieve color, smell, taste, and texture comparable to the herbal
      granules. Patients are instructed to dissolve the granules in 150ml of hot water, twice daily
      for two weeks. The primary end point is the global symptom improvement. Secondary outcome
      measures include stool frequency, stool form, use of rescue herbal granules, constipation
      visual analogue scale (CVAS) (0=none to 7=most severe) and individual assessment of
      constipation related symptoms. For the safety profiles of herbal intervention, the important
      adverse events reported and clinical laboratory evaluations of liver and renal function are
      determined.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global symptom improvement (improved / same / worse)</measure>
    <time_frame>2 weeks</time_frame>
    <description>Participants are asked to rate their impression of change in constipation symptoms in comparison with their baseline, with scores from 0 to 6 represents markedly worse or better at the respective extremes. The response categories are collapsed to simply &quot;improved&quot; for score 4-6, &quot;same&quot; for score 3, or &quot;worse&quot; for score 0-2.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of bowel movement (times/day)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool form</measure>
    <time_frame>2 weeks</time_frame>
    <description>Stool form is assessed with 7-point Bristol Stool Scale (ranging from &quot;separate hard lumps&quot; to &quot;watery&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extra laxatives used (times/week)</measure>
    <time_frame>2 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constipation visual analogue scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>The severity of constipation is evaluated by an eight point ordinal rating scale (0=none to 7=most severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constipation related symptoms</measure>
    <time_frame>2 weeks</time_frame>
    <description>Sensation of straining, incomplete evacuation, bloating, abdominal pain/cramping, nausea, and passing of gas are recorded using a 7-point ordinal scale (0=not at all and 6=very severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood creatinine level (umol/L)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood urea level (mmol/L)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum glutamic pyruvic transaminase(SGPT) Level (U/L)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Glutamic Oxaloacetic Transaminase (SGOT) Level (U/L)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Chinese herbal medicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MaZiRenWan 10g plus HuangQi 20g are chosen as the core prescription. Furthermore, six herbal granules can be added according to the syndrome differentiated for individual participant. They are ShuDiHuang 15g and Danggui 10g for deficiency of blood, Maidong 15g and ShengDiHuang 10g for deficiency of Yin, and RouCongRong 15g and Niuxi 10g for deficiency of Yang.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo is made from dextrin (76.03%), tea essence (23.61%), gardenin (0.02%), and caramel (0.34%) to achieve color, smell, taste, and texture comparable to the herbal granules.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chinese herbal medicine</intervention_name>
    <arm_group_label>Chinese herbal medicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severity of constipation &gt; 3 points (an 8-point scale from 0 to 7)

          -  Palliative Performance Scale â‰¥60%

          -  Relatively stable liver and renal function within 3 months

          -  Patients who can read and speak Chinese

        Exclusion Criteria:

          -  Inability to communicate

          -  Presence of a colostomy, or gastrointestinal obstruction

          -  Presence of loose or watery stool (Bristol stool scale 6-7) or bowel movement &gt; 3/day
             under routine laxative treatment

          -  History of Chinese herbal medicine allergies

          -  Estimated life expectancy less than 1 month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhao-xiang Bian, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hong Kong Baptist University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhao-xiang Bian, PhD</last_name>
    <phone>852-34112905</phone>
    <email>bzxiang@hkbu.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chung-wah Cheng, Mphil</last_name>
    <phone>852-34116521</phone>
    <email>hollie@hkbu.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Caritas Medical Centre</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhao-xiang Bian, PhD</last_name>
      <phone>852-34112905</phone>
      <email>bzxiang@hkbu.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Chung-wah Cheng, Mphil</last_name>
      <phone>852-34116521</phone>
      <email>hollie@hkbu.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Annie OL Kwok, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hong Kong Buddhist Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhao-xiang Bian, PhD</last_name>
      <phone>(852)34112905</phone>
      <email>bzxiang@hkbu.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Hollie Cheng, Mphil</last_name>
      <phone>(852)34116521</phone>
      <email>hollie@hkbu.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Cora WS Yau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Our Lady of Maryknoll Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhao-xiang Bian, PhD</last_name>
      <phone>(852)34112905</phone>
      <email>bzxiang@hkbu.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Hollie CW Cheng, Mphil</last_name>
      <phone>(852)34116521</phone>
      <email>hollie@hkbu.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Jasmine TM Chan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <removed_countries>
    <country>China</country>
  </removed_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2016</study_first_submitted>
  <study_first_submitted_qc>June 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2016</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hong Kong Baptist University</investigator_affiliation>
    <investigator_full_name>ZhaoXiang Bian</investigator_full_name>
    <investigator_title>Chair Professor, Director</investigator_title>
  </responsible_party>
  <keyword>Chinese herbal medicine formula</keyword>
  <keyword>MaZiRenWan</keyword>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Constipation</keyword>
  <keyword>Palliative care in cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Research results will be published after analysis.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

